Galderma agrees to buy ZO Skin Health for around $1.5 billion
BX•Galderma has agreed to buy medical-grade skincare company ZO Skin Health for around $1.5 billion, according to two people familiar with the matter. A deal could be announced in the coming days.
1. Proposed acquisition
Swiss skincare company Galderma has agreed to buy ZO Skin Health for around $1.5 billion, according to two people familiar with the matter. A deal could be announced in the coming days.
2. Companies and ownership
ZO's owner, Blackstone, had been exploring a sale of the company with investment banks. L'Oréal owns a 20% stake in Galderma, which also owns Cetaphil and Alastin Skincare, among other brands.
